Burkert Pieske

100.9k total citations · 14 hit papers
590 papers, 30.5k citations indexed

About

Burkert Pieske is a scholar working on Cardiology and Cardiovascular Medicine, Molecular Biology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Burkert Pieske has authored 590 papers receiving a total of 30.5k indexed citations (citations by other indexed papers that have themselves been cited), including 468 papers in Cardiology and Cardiovascular Medicine, 111 papers in Molecular Biology and 73 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Burkert Pieske's work include Cardiovascular Function and Risk Factors (217 papers), Heart Failure Treatment and Management (141 papers) and Cardiac electrophysiology and arrhythmias (124 papers). Burkert Pieske is often cited by papers focused on Cardiovascular Function and Risk Factors (217 papers), Heart Failure Treatment and Management (141 papers) and Cardiac electrophysiology and arrhythmias (124 papers). Burkert Pieske collaborates with scholars based in Germany, United States and Austria. Burkert Pieske's co-authors include Gerd Hasenfuß, Lars S. Maier, Adriaan A. Voors, Carsten Tschöpe, Scott D. Solomon, Frank Edelmann, Elisabeth Kraigher‐Krainer, John J.V. McMurray, H. Just and Rolf Wachter and has published in prestigious journals such as New England Journal of Medicine, Proceedings of the National Academy of Sciences and The Lancet.

In The Last Decade

Burkert Pieske

568 papers receiving 29.9k citations

Hit Papers

2014 ESC Guidelines on di... 1994 2026 2004 2015 2014 2007 2012 2020 2010 500 1000 1.5k 2.0k 2.5k
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. 2014 ESC Guidelines on diagnosis and management of hypertrophic cardiomyopathy
    2014 2.9k citations Burkert Pieske, Hugh Watkins et al. profile →
  2. How to diagnose diastolic heart failure: a consensus statement on the diagnosis of heart failure with normal left ventricular ejection fraction by the Heart Failure and Echocardiography Associations of the European Society of Cardiology
    2007 1.9k citations Gilles W. De Keulenaer, Burkert Pieske et al. profile →
  3. The angiotensin receptor neprilysin inhibitor LCZ696 in heart failure with preserved ejection fraction: a phase 2 double-blind randomised controlled trial
    2012 853 citations Scott D. Solomon, Michael R. Zile et al. profile →
  4. Vericiguat in Patients with Heart Failure and Reduced Ejection Fraction
    2020 735 citations Burkert Pieske, Carolyn S.P. Lam et al. profile →
  5. Current State of Knowledge on Aetiology, Diagnosis, Management, and Therapy of Peripartum Cardiomyopathy: A Position Statement from the Heart Failure Association of the European Society of Cardiology Working Group on peripartum cardiomyopathy
    2010 608 citations Karen Sliwa, Denise Hilfiker‐Kleiner et al. European Journal of Heart Failure profile →
  6. Relation between myocardial function and expression of sarcoplasmic reticulum Ca(2+)-ATPase in failing and nonfailing human myocardium.
    1994 605 citations Gerd Hasenfuß, Burkert Pieske et al. Circulation Research profile →
  7. Mitochondrial function as a therapeutic target in heart failure
    2016 539 citations Adriaan A. Voors, Stefan D. Anker et al. profile →
  8. Effect of Spironolactone on Diastolic Function and Exercise Capacity in Patients With Heart Failure With Preserved Ejection Fraction
    2013 513 citations Frank Edelmann, Rolf Wachter et al. profile →
  9. Impaired Systolic Function by Strain Imaging in Heart Failure With Preserved Ejection Fraction
    2013 511 citations Elisabeth Kraigher‐Krainer, Amil M. Shah et al. profile →
  10. Altered microRNA expression in human heart disease
    2007 505 citations Egbert Bisping, Burkert Pieske et al. profile →
  11. Exercise Training in Heart Failure: From Theory to Practice. A Consensus Document of the Heart Failure Association and the European Association for Cardiovascular Prevention and Rehabilitation
    2011 466 citations Massimo Piepoli, Viviane M. Conraads et al. European Journal of Heart Failure profile →
  12. Exercise Training Improves Exercise Capacity and Diastolic Function in Patients With Heart Failure With Preserved Ejection Fraction
    2011 435 citations Frank Edelmann, Rolf Wachter et al. profile →
  13. Effect of Vericiguat, a Soluble Guanylate Cyclase Stimulator, on Natriuretic Peptide Levels in Patients With Worsening Chronic Heart Failure and Reduced Ejection Fraction
    2015 271 citations Gerasimos Filippatos, Carolyn S.P. Lam et al. profile →
  14. Effect of Vericiguat vs Placebo on Quality of Life in Patients With Heart Failure and Preserved Ejection Fraction
    2020 176 citations Carolyn S.P. Lam, Burkert Pieske et al. profile →

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Burkert Pieske 23.8k 7.3k 3.7k 2.9k 2.4k 590 30.5k
Roberto Ferrari 19.5k 0.8× 5.5k 0.8× 5.4k 1.4× 3.4k 1.2× 2.1k 0.9× 754 30.5k
Gerd Hasenfuß 22.8k 1.0× 9.7k 1.3× 4.8k 1.3× 4.0k 1.4× 2.3k 1.0× 599 31.7k
Michael R. Bristow 30.6k 1.3× 11.2k 1.5× 4.7k 1.3× 2.1k 0.7× 2.2k 0.9× 399 39.8k
Michael R. Zile 32.2k 1.4× 4.4k 0.6× 4.9k 1.3× 3.7k 1.3× 4.4k 1.8× 570 38.3k
David M. Kaye 15.0k 0.6× 4.5k 0.6× 3.9k 1.1× 2.0k 0.7× 2.5k 1.0× 606 25.9k
Arthur M. Feldman 21.4k 0.9× 6.8k 0.9× 4.3k 1.2× 1.6k 0.5× 1.8k 0.7× 328 28.9k
John C. Burnett 22.6k 0.9× 6.0k 0.8× 3.6k 1.0× 2.2k 0.8× 5.4k 2.3× 570 31.4k
Philip A. Poole‐Wilson 17.5k 0.7× 3.2k 0.4× 3.0k 0.8× 2.0k 0.7× 3.0k 1.3× 197 25.6k
Hiroyuki Tsutsui 11.3k 0.5× 7.0k 1.0× 2.7k 0.7× 1.3k 0.5× 2.0k 0.8× 638 21.7k
Arshed A. Quyyumi 14.5k 0.6× 5.0k 0.7× 5.3k 1.4× 4.0k 1.4× 2.7k 1.1× 473 28.9k

Countries citing papers authored by Burkert Pieske

Since Specialization
Citations

This map shows the geographic impact of Burkert Pieske's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Burkert Pieske with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Burkert Pieske more than expected).

Fields of papers citing papers by Burkert Pieske

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Burkert Pieske. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Burkert Pieske. The network helps show where Burkert Pieske may publish in the future.

Co-authorship network of co-authors of Burkert Pieske

This figure shows the co-authorship network connecting the top 25 collaborators of Burkert Pieske. A scholar is included among the top collaborators of Burkert Pieske based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Burkert Pieske. Burkert Pieske is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Hohendanner, Felix, Sebastian Scholz, Volkmar Falk, et al.. (2023). Mechanistic assessment and ablation of left ventricular assist device related ventricular tachycardia in patients with severe heart failure. Frontiers in Physiology. 14. 1086730–1086730. 2 indexed citations
2.
Bode, David, Christian U. Oeing, Alessio Alogna, et al.. (2021). Implications of SGLT Inhibition on Redox Signalling in Atrial Fibrillation. International Journal of Molecular Sciences. 22(11). 5937–5937. 8 indexed citations
3.
Alushi, Brunilda, Thomas Wurster, David M. Leistner, et al.. (2019). Impella versus IABP in acute myocardial infarction complicated by cardiogenic shock. Open Heart. 6(1). e000987–e000987. 55 indexed citations
4.
Voelkl, Jakob, Rashad Tuffaha, Trang T. D. Luong, et al.. (2018). Zinc Inhibits Phosphate-Induced Vascular Calcification through TNFAIP3-Mediated Suppression of NF-κB. Journal of the American Society of Nephrology. 29(6). 1636–1648. 123 indexed citations
5.
Tuffaha, Rashad, Jakob Voelkl, Burkert Pieske, Florian Läng, & Ioana Alesutan. (2018). Role of PKB/SGK-dependent phosphorylation of GSK-3α/β in vascular calcification during cholecalciferol overload in mice. Biochemical and Biophysical Research Communications. 503(3). 2068–2074. 15 indexed citations
6.
Blaschke, Florian, Alexander Wutzler, Martin Huemer, et al.. (2017). Managing periprocedural anticoagulation therapy in patients undergoing device implantation: survey in Germany, Austria and Switzerland.. PubMed. 71(5). 549–556. 1 indexed citations
7.
Ljubojević-Holzer, Senka, Snježana Radulović, Gerd Leitinger, et al.. (2014). Early Remodeling of Perinuclear Ca 2+ Stores and Nucleoplasmic Ca 2+ Signaling During the Development of Hypertrophy and Heart Failure. Circulation. 130(3). 244–255. 61 indexed citations
8.
Corrà, Ugo, Massimo Piepoli, Stamatis Adamopoulos, et al.. (2014). Cardiopulmonary Exercise Testing in Systolic Heart Failure in 2014: The Evolving Prognostic Role. European Journal of Heart Failure. 16(9). 929–941. 65 indexed citations
9.
Gori, Mauro, Carolyn S.P. Lam, Deepak K. Gupta, et al.. (2014). Sex-Specific Cardiovascular Structure and Function in Heart Failure with Preserved Ejection Fraction. European Journal of Heart Failure. 16(5). 535–542. 171 indexed citations
10.
Hohendanner, Felix, Senka Ljubojević-Holzer, Niall Macquaide, et al.. (2013). Intracellular Dyssynchrony of Diastolic Cytosolic [Ca 2+ ] Decay in Ventricular Cardiomyocytes in Cardiac Remodeling and Human Heart Failure. Circulation Research. 113(5). 527–538. 44 indexed citations
11.
Boer, Rudolf A. de, Frank Edelmann, Alain Cohen‐Solal, et al.. (2013). Galectin-3 in Heart Failure with Preserved Ejection Fraction. European Journal of Heart Failure. 15(10). 1095–1101. 81 indexed citations
12.
Conraads, Viviane M., Marco Metra, Otto Kamp, et al.. (2011). Effects of the Long-Term Administration of Nebivolol on the Clinical Symptoms, Exercise Capacity, and Left Ventricular Function of Patients with Diastolic Dysfunction: Results of the ELANDD Study. European Journal of Heart Failure. 14(2). 219–225. 155 indexed citations
13.
Piepoli, Massimo, Viviane M. Conraads, Ugo Corrà, et al.. (2011). Exercise Training in Heart Failure: From Theory to Practice. A Consensus Document of the Heart Failure Association and the European Association for Cardiovascular Prevention and Rehabilitation. European Journal of Heart Failure. 13(4). 347–357. 466 indexed citations breakdown →
14.
Sliwa, Karen, Denise Hilfiker‐Kleiner, Mark C. Petrie, et al.. (2010). Current State of Knowledge on Aetiology, Diagnosis, Management, and Therapy of Peripartum Cardiomyopathy: A Position Statement from the Heart Failure Association of the European Society of Cardiology Working Group on peripartum cardiomyopathy. European Journal of Heart Failure. 12(8). 767–778. 608 indexed citations breakdown →
15.
Post, H., Michael Schwarzl, Paul Steendijk, et al.. (2010). Coronary microembolisation induces acute and progressive diastolic heart failure. Data Archiving and Networked Services (DANS). 1 indexed citations
16.
17.
Lewinski, Dirk von, Jens Kockskämper, Jan D. Schmitto, et al.. (2008). Direct Pro-Arrhythmogenic Effects of Angiotensin II can be Suppressed by AT1 Receptor Blockade in Human Atrial Myocardium. European Journal of Heart Failure. 10(12). 1172–1176. 36 indexed citations
18.
Wachter, Rolf, Claus Lüers, Christoph Herrmann‐Lingen, et al.. (2007). Impact of Diabetes on Left Ventricular Diastolic Function in Patients with Arterial Hypertension. European Journal of Heart Failure. 9(5). 469–476. 24 indexed citations
19.
Lewinski, Dirk von, et al.. (2007). Mechanistic Insight Into the Functional and Toxic Effects of Strophanthidin in the Failing Human Myocardium. European Journal of Heart Failure. 9(11). 1086–1094. 10 indexed citations
20.
Hermann, Hans‐Peter, et al.. (2004). Improved Systolic and Diastolic Myocardial Function with Intracoronary Pyruvate in Patients with Congestive Heart Failure. European Journal of Heart Failure. 6(2). 213–218. 27 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Roberto Ferrari Breakdown of academic impact, for papers by Gerd Hasenfuß Breakdown of academic impact, for papers by Michael R. Bristow Breakdown of academic impact, for papers by Michael R. Zile Breakdown of academic impact, for papers by David M. Kaye Breakdown of academic impact, for papers by Arthur M. Feldman Breakdown of academic impact, for papers by John C. Burnett Breakdown of academic impact, for papers by Philip A. Poole‐Wilson Breakdown of academic impact, for papers by Hiroyuki Tsutsui Breakdown of academic impact, for papers by Arshed A. Quyyumi
Rankless by CCL
2026